Bristol Myers Squibb New Brunswick Gas Power Plant | New Jersey, USA

Bristol Myers Squibb New Brunswick is a gas-fired power generation facility located in New Brunswick, New Jersey, United States. With a capacity of 10.5 MW, it is a small-scale plant primarily serving the energy needs of the Bristol-Myers Squibb pharmaceutical campus. The plant operates under the regulatory framework of the US Environmental Protection Agency, including the Clean Air Act and associated programs such as the Acid Rain Program and CSAPR. The facility uses natural gas as its primary fuel, which produces lower CO2, SOx, and NOx emissions compared to coal or oil. Its small capacity and modern gas turbine technology contribute to a relatively efficient and cleaner operation. The plant is situated in an urban area, close to residential and commercial zones, which necessitates compliance with local air quality standards. As an on-site cogeneration or backup power source for a major pharmaceutical company, this plant plays a critical role in ensuring reliable energy supply for manufacturing processes. Its operation supports the local economy and grid stability, while its gas-fired technology aligns with broader trends toward cleaner energy in the power generation sector.

The plant's gas-fired technology results in lower greenhouse gas and pollutant emissions per MWh compared to coal or oil plants. Its location in an urban area means it must adhere to strict local air quality regulations, including NAAQS. The small capacity limits its overall environmental footprint, but continuous monitoring and compliance with EPA standards are essential to minimize impact on the surrounding community.